Corpus ID: 6132012

Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.

  title={Carvedilol--a beta-blocker with considerable antiaggregatory effect on human blood platelets.},
  author={M. Petr{\'i}kov{\'a} and V. Jan{\vc}inov{\'a} and R. Nos{\'a}l' and M. Majekova and V. F{\'a}bryov{\'a}},
  journal={Bratislavske lekarske listy},
  volume={106 1},
BACKGROUND Activated blood platelets play a key role in the genesis of many pathological states. Several studies have documented that beta-blockers can influence platelet aggregation. Carvedilol, a third generation non-selective agent with vasodilatory properties, is successfully used in pathological states accompanied with platelet hyperreactivity, however information on its antiplatelet activity is lacking. OBJECTIVES The aim of this study was to analyse the in vitro effect of carvedilol on… Expand
14 Citations
Interindividual variability in the efficacy of oral antiplatelet drugs: definitions, mechanisms and clinical importance.
  • 54
Thrombolome and Its Emerging Role in Chronic Kidney Diseases
  • PDF
Platelets and Hemostasis
Intravenous Lipid Emulsion Does Not Augment Blood Pressure Recovery in A Rabbit Model of Metoprolol Toxicity
  • 36
  • PDF